Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2016-07-15

Clinical Trial Update: Feasibility Study to Develop Sentinel Lymph Node Mapping in Rectal Cancer Patients [NA]

View source ↗

Summary

A feasibility study on sentinel lymph node mapping in rectal cancer patients has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Virginia | Conditions: Rectal Cancer | NA | Status: WITHDRAWN